Cancer Treatment During a Pandemic People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered. by William G. Nelson, MD, PhD Testing Cancer Patients for the Coronavirus Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus. by Anna Azvolinsky From The Editor-In-Chief Cancer Epigenetics: Disorganization Drives Dysfunction Emerging insights into epigenetic abnormalities in cancer cells may lead to better cancer outcomes. by William G. Nelson, MD, PhD FORWARD LOOK Cryoablation May Be a Treatment Option for Some Patients Procedure uses extreme cold to kill cancer cells. by Christina Bennett Forward Look More Options to Prevent Blood Clots in High-Risk Cancer Patients Updated guidelines support use of oral blood thinners. by Jane Langille Q&A A Different Mountaintop Science writer Charles Graeber describes how a shift in researchers’ understanding of immune function and cancer is leading to effective treatments. by Marci A. Landsmann FORWARD LOOK New Guidelines for Radiation Therapy in Pancreatic Cancer Recommendations address conflicts and research gaps. by Ashley P. Taylor FORWARD LOOK Managing Opioid-Related Constipation Patients may be wary of discussing this common side effect. by Sue Rochman Can CRISPR Deliver? A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients? by Stephen Ornes The Puzzle of Pancreatic Cancer Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend. by Kendall K. Morgan next Cancer Talk Cancer Treatment During a Pandemic People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered. by William G. Nelson, MD, PhD Testing Cancer Patients for the Coronavirus Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus. by Anna Azvolinsky The Coronavirus Impacts Cancer Clinical Trials The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials. by Anna Azvolinsky A Unified Strategy A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data. by Marci A. Landsmann More Posts